Department of Medicine

University of Pittsburgh

Division of Endocrinology and Metabolism
200 Lothrop Street
E1140 BST
Pittsburgh, PA 15213

Administrative/Research Office:
(412) 648-9770

Patient/Clinical Inquiries:
(412) 586-9700

Robert M. O'Doherty, PhD

photo

Associate Professor of Medicine

Associate Professor of Biochemistry and Molecular Genetics

Director, T32 Diabetes and Endocrinology Training Program

Director, Center for Metabolic and Mitochondrial Medicine (C3M)

Office: E1140 Biomedical Science Tower
200 Lothrop Street
Pittsburgh, PA 15261
 
Phone: 412-648-3320
Fax: 412-648-3290
E-mail: rmo1@pitt.edu

Education
B.A., University of Dublin, 1986
PhD, Vanderbilt University, 1995

Training
Postdoctoral Fellow, Diabetes/Obesity, University of Texas, Southwestern Medical Center, 1998

Area of Specialization/Research Interest  
Immunobiology of Metabolic dysregulation in obesity/ T2DM/ NAFLD
 

Profile
Dr. O'Doherty graduated from Trinity College Dublin, Ireland in 1986 with a BA (Mod) in Zoology and in 1995 took a PhD at Vanderbilt University, Nashville, TN., USA. After completing a post-doctoral fellowship at University of Texas Southwestern Medical Center, he joined the faculty of the Departments of Medicine, Division of Endocrinology and Metabolism and Microbiology and Molecular Genetics at the University of Pittsburgh in 1999. He is currently an Associate Professor of Medicine, and Microbiology and Molecular Genetics, Director of the T32 training program in Diabetes and Endocrinology, and Director of the Center for Metabolic and Mitochondrial Medicine (C3M). The major foci of Dr. O'Doherty's current research efforts are in the area of immunometabolism, that is the role of immune system components in the regulation of metabolism, particularly in disease states such as obesity, NAFLD, and Type 2 Diabetes. We have accumulated extensive experience in this arena over the last 20 years, utilizing a range of metabolic, physiological, biochemical, molecular and immunological approaches in a range of mouse, primary tissue, and immortal cell lines.

Lab Personnel and Web page
View Lab Webpage
Recent Grants
Title: Epigenomic Regulation of Gene Expression in Diet Induced Obesity
Role: Co-Investigator
Amount: $450,000
Funding Agency: NIH
Start Year: 2011
End Year: 2013
Title: Leptin Action and Macrophages
Role: PI
Amount: $1,200,000
Funding Agency: NIH
Start Year: 2011
End Year: 2015
Title: Mechanisms for Aresenic Induced Vascular Disease
Role: Co-Investigator
Amount: $180,000
Funding Agency: NIH
Start Year: 2010
End Year: 2011
Title: The Role of Myc in ChREBP-dependent Glucose-stimulated Gene Expression
Role: Co-Investigator
Amount: $900,000
Funding Agency: NIH
Start Year: 2006
End Year: 2011
Title: Lipids, Inflammatory Pathways and Insulin Resistance
Role: PI
Amount: $1,200,000
Funding Agency: NIH
Start Year: 2006
End Year: 2011

For Pub Med search results, click here.